Sai Parenteral's IPO GMP today is Rs 8. Investors can use this GMP along with price band and subscription status for a better IPO review.
Listed
Mainboard IPO
SAIPARENTERALS
Sai Parenteral's IPO GMP, Subscription & Allotment Status Today
Sai Parenteral’s IPO is a mainboard public issue of a pharmaceutical company engaged in the manufacturing of branded generic formulations and providing contract development and manufacturing (CDMO) services across domestic and international markets. The IPO comprises a mix of fresh issue (around ₹285 crore) and an offer for sale, with proceeds primarily aimed at capacity expansion, R&D development, debt repayment, and working capital needs. The issue opened on 24 March 2026 and closed on 27 March 2026, with a price band of ₹372–₹392 per share, attracting attention due to its presence in the growing pharmaceutical and export-focused segment. With a diversified product portfolio and improving financial performance, the company operates in a high-growth pharma sector, offering potential long-term opportunities for investors.
- Price Band
- ₹372.00 - ₹392.00
- Lot Size
- 38 Shares
- Bidding Closes
- 27 Mar 2026
- Listing Date
- 02 Apr 2026
Current GMP Status
₹8
+2.04% vs upper band
Est. Listing Gain
+2.04%
Last Trend
25 Mar 2026
Listing Price
₹400.00
Retail Entry
₹14,896
IPO Details
Complete IPO information
| Current GMP | ₹8 |
|---|---|
| Estimated Listing Gain | +2.04% |
| Price Band | ₹372.00 - ₹392.00 |
| Issue Price | Approx ₹392.00 Crores |
| Listing Price | ₹400.00 |
| Lot Size | 38 Shares |
| Issue Type | Mainboard |
| Registrar | TBA |
| Exchange | NSE, BSE |
| Retail Quota | TBA |
| Overall Subscription | 0.05x |
| Listing Date | 02 Apr 2026 |
| Minimum Investment | ₹14,896 |
Analysis
IPO Snapshot & Investor Takeaways
At the upper end of its price band, Sai Parenteral's is priced at ₹392 per share. With a minimum lot size of 38 shares, a retail investor applying for one lot would need approximately ₹14,896 to participate in this Mainboard issue.
The latest recorded Grey Market Premium for Sai Parenteral's stands at ₹8, implying an estimated listing gain of around 2.04% over the issue price if it holds until listing. GMP reflects informal grey-market sentiment rather than a guaranteed outcome, and can change at any point until the day of listing.
As of the latest update, Sai Parenteral's's IPO was subscribed 0.05x overall, with a category-wise breakdown of Retail 0.03x, QIB 0x.
Mainboard IPOs list on the main platform of BSE/NSE, typically involve larger issue sizes, and draw participation across retail, HNI and institutional (QIB) investor categories.
Timeline
IPO roadmap at a glance
✓
Bidding Opens
24 Mar 2026
✓
Bidding Closes
27 Mar 2026
✓
Allotment
TBA
✓
Listing
02 Apr 2026
Grey Market Premium
Daily GMP status
| Date | GMP | Change | Gain |
|---|---|---|---|
| 25 Mar 2026 | ₹0.00 | - | 0.00% |
| 23 Mar 2026 | ₹0.00 | - | 0.00% |
| 19 Mar 2026 | ₹0.00 | - | 0.00% |
Swipe to see more →
Market Lot
Application size breakdown
| Category | Lots | Shares | Amount |
|---|---|---|---|
| Retail Minimum | 1 Lot | 38 | ₹14,896 |
| Retail Maximum | 13 Lot | 494 | ₹1,93,648 |
| S-HNI Minimum | 14 Lot | 532 | ₹2,08,544 |
| S-HNI Maximum | 67 Lot | 2,546 | ₹9,98,032 |
| B-HNI Minimum | 68 Lot | 2,584 | ₹10,12,928 |
Swipe to see more →
Fund Utilization
Objects of the Issue & Official Documents
Analysis
Sai Parenteral’s IPO Details
| IPO Open Date | March 24, 2026 |
|---|---|
| IPO Close Date | March 27, 2026 |
| Face Value | ₹5 Per Equity Share |
| IPO Price Band | ₹372 to ₹392 Per Share |
| Issue Size | Approx ₹409 Crores |
| Fresh Issue | Approx ₹285 Crores |
| Offer for Sale | Approx 35,00,000 Equity Shares |
| Issue Type | Book Build Issue |
| IPO Listing | BSE, NSE |
Analysis
Sai Parenteral’s IPO Reservation
| Investor Category | Shares Offered | Shares (%) |
|---|---|---|
| Anchor Investor | — Shares | —% |
| QIB (Ex. Anchor) | — Shares | 50% |
| NII | — Shares | 15% |
| Retail | — Shares | 35% |
Analysis
Sai Parenteral’s IPO Anchor Investors
| Anchor Bidding Date | March 23, 2026 |
|---|---|
| Shares Offered | — Shares |
| Anchor Size | ₹ — Cr. |
| Lock-in Period (50% Shares - 30 Days) | 2026 |
| Lock-in Period (50% Shares - 90 Days) | 2026 |
Analysis
Sai Parenteral’s IPO Dates
| IPO Open Date | March 24, 2026 |
|---|---|
| IPO Close Date | March 27, 2026 |
| Basis of Allotment | March 30, 2026 |
| Refunds | April 1, 2026 |
| Credit to Demat Account | April 1, 2026 |
| IPO Listing Date | April 2, 2026 |
| Bidding Cut-off Time | March 27, 2026 – 5 PM |
Analysis
Sai Parenteral’s IPO Promoters & Holding Pattern
| Particular | Shares | % Share |
|---|---|---|
| Promoter Holding Pre Issue | 3,69,08,823 | 61.23% |
| Promoter Holding Post Issue | 4,41,79,231 | - |
| Promoters |
|---|
| Anil Kumar Karusala, Vijitha Gorrepati and Karusala Aruna |
Analysis
Sai Parenteral’s IPO – Objects of the Issue
| Purpose | Amount (₹ Cr.) |
|---|---|
| Capacity Expansion & Upgradation | 110.80 |
| New R&D Centre | 18.02 |
| Repayment / Prepayment of Borrowings | 20.00 |
| Working Capital Requirements | 33.00 |
| Investment in Subsidiary (Singapore) for Acquisition | 36.00 |
| General Corporate Purpose | — |
Analysis
About Sai Parenteral’s IPO
Sai Parenteral’s Ltd., founded in 2001, is one of the leading pharmaceutical companies focused on R&D and manufacturing of pharmaceutical products. The firm operates in 2 main business areas: makes and sells its own branded medicines, and also manufactures medicines for other companies internationally. Its product offerings include a wide range of medicines for various health conditions, like cardiovascular, neuropsychiatry, anti-diabetic, respiratory health, antibiotics, gastroenterology, vitamins, minerals, and supplements (VMS), analgesics, and dermatology.
Its medicines are available in various forms like tablets, injections, and syrups. Sai Parenteral’s major clients are government agencies, pharmaceutical companies, public and private hospitals, and large distributors in India. The firm operates 5 manufacturing facilities in India, mainly located in Hyderabad, known for developing medicines with international quality certifications.
Analysis
Sai Parenteral’s IPO Company Financial Report
| Period Ended | Revenue (₹ Cr.) | Expense (₹ Cr.) | PAT (₹ Cr.) | Assets (₹ Cr.) |
|---|---|---|---|---|
| 2023 | 97.03 | 89.78 | 4.38 | 133.96 |
| 2024 | 155.18 | 142.63 | 8.42 | 268.10 |
| 2025 | 163.74 | 143.84 | 14.43 | 272.39 |
| Sep 2025 | 89.43 | 78.27 | 7.76 | 376.24 |
Analysis
Sai Parenteral’s IPO Valuation – FY2025
| KPI | Values |
|---|---|
| ROE | 15.09% |
| ROCE | 28.92% |
| EBITDA Margin | 24.18% |
| PAT Margin | 8.88% |
| Debt to Equity | — |
| EPS (Basic) | ₹5.43 |
| P/E Ratio | N/A |
| RoNW | 15.09% |
| NAV | ₹35.98 |
Analysis
Sai Parenteral’s IPO Peer Group Comparison
| Company | EPS | P/E Ratio | RoNW % | NAV | Income (₹ Cr.) |
|---|---|---|---|---|---|
| Sai Life Sciences Limited | 8.83 | 107.70 | 7.99% | 102.12 | 1,694.57 |
| InnovaCaptab Limited | 22.41 | 32.45 | 13.37% | 167.66 | 1,243.68 |
| Senores Pharmaceuticals Limited | 16.12 | 64.30 | 7.18% | 176.37 | 398.25 |
| Gland Pharma Limited | 42.40 | 44.71 | 7.63% | 555.41 | 5,616.50 |
| Industry Average | — | 62.29 | — | — | — |
Analysis
IPO Lead Managers aka Merchant Bankers
- Arihant Capital Markets Ltd.
FAQ
Sai Parenteral's IPO FAQs
Sai Parenteral's IPO price band is Rs 372.00 to Rs 392.00. Check the latest issue price, lot size and GMP together before applying.
Sai Parenteral's IPO open date is 24 Mar 2026, close date is 27 Mar 2026, and listing date is 02 Apr 2026.
Sai Parenteral's IPO lot size is 38 shares. The minimum retail investment is Rs 14,896.
Sai Parenteral's is classified as a Mainboard IPO. This helps investors quickly understand the issue category and exchange segment.
Sai Parenteral's IPO subscription status currently shows Retail 0.03x, QIB 0x, Overall 0.05x.
Sai Parenteral’s IPO is a mainboard public issue of a pharmaceutical company engaged in the manufacturing of branded generic formulations and providing contract development and manufacturing (CDMO) services across domestic and international markets. The IPO comprises a mix of fresh issue (around ₹285 crore) and an offer for sale, with proceeds primarily aimed at capacity expansion, R&D development, debt repayment, and working capital needs. The issue opened on 24 March 2026 and closed on 27 March 2026, with a price band of ₹372–₹392 per share, attracting attention due to its presence in the growing pharmaceutical and export-focused segment. With a diversified product portfolio and improving financial performance, the company operates in a high-growth pharma sector, offering potential long-term opportunities for investors.
Community discussion
Comments
Share a useful question or insight about Sai Parenteral's.
Leave a comment
Your email address will not be published. All comments and replies are reviewed before appearing.
Keep Exploring
Similar Recent IPOs
Upcoming
Mainboard
Sonaselection
Current GMP₹0
Price Band₹94.00 - ₹99.00
Lot Size150 Shares
Upcoming
Mainboard
NSE
Current GMP₹208+11.7%
Price Band₹1700.00 - ₹1785.00
Lot Size8 Shares
Open
Mainboard
Jindal Supreme (India)
Current GMP₹0
Price Band₹88.00 - ₹93.00
Lot Size161 Shares
Open
Mainboard
Hero Motors
Current GMP₹24+28.6%
Price Band₹79.00 - ₹84.00
Lot Size178 Shares
Loading comments...